Amidst recent fluctuations in global markets, driven by tariff uncertainties and mixed economic data, investors are seeking opportunities that might be overlooked. In this environment, identifying ...

Its sister company WuXi Biologics rose 4.7%, while WuXi XDC, a contract medical research unit of WuXi Biologics, was up 5.0%. The WuXi companies have come under scrutiny amid tensions between the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

At close: 4 February at 7:30:36 pm GMT+1 ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

At close: 4:08:30 p.m. GMT+8 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

STA Pharmaceutical Hong Kong Investment, the shareholder of WUXI XDC (02268.HK), placed 37.8 million shares of the company at $30.855-31.515 per share, a discount of ...

A Aaaaaaaaa A 113.32 +22.98% ...

We've identified the following companies as similar to WuXi XDC Cayman Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to ...